Heliotis M, Lavery K M, Ripamonti U, Tsiridis E, di Silvio L
Department of Maxillofacial Surgery, Queen Victoria Hospital, Holtye Road, East Grinstead, West Sussex RH19 3DZ, UK.
Int J Oral Maxillofac Surg. 2006 Mar;35(3):265-9. doi: 10.1016/j.ijom.2005.07.013. Epub 2005 Oct 28.
We describe the intramuscular transformation of a hydroxyapatite/osteogenic protein-1 (HA/OP-1) composite implant, into a vascularised pedicled bone flap useful for reconstruction of a hemi-mandible. Extraskeletal induction of a bone flap for transplantation was achieved without the addition of harvested bone, bone marrow, or stem cells. Five months after apparent clinical success, an MRSA infection of the graft led to its failure. The background to ectopically induced bone flaps is introduced, with our experience in a human case presented. The results from this emerging biotechnology are discussed in the light of limited human clinical experience.
我们描述了一种羟基磷灰石/成骨蛋白-1(HA/OP-1)复合植入物的肌内转化,使其成为用于半侧下颌骨重建的带血管蒂骨瓣。在不添加采集的骨、骨髓或干细胞的情况下,实现了用于移植的骨瓣的体外诱导。在明显取得临床成功五个月后,移植物发生耐甲氧西林金黄色葡萄球菌感染,导致手术失败。本文介绍了异位诱导骨瓣的背景,并分享了我们在一例人类病例中的经验。鉴于有限的人类临床经验,对这种新兴生物技术的结果进行了讨论。